Jiri Keirsse

1.7k total citations
19 papers, 1.3k citations indexed

About

Jiri Keirsse is a scholar working on Immunology, Molecular Biology and Cancer Research. According to data from OpenAlex, Jiri Keirsse has authored 19 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 7 papers in Molecular Biology and 3 papers in Cancer Research. Recurrent topics in Jiri Keirsse's work include Immune cells in cancer (12 papers), Immune Cell Function and Interaction (7 papers) and Immunotherapy and Immune Responses (5 papers). Jiri Keirsse is often cited by papers focused on Immune cells in cancer (12 papers), Immune Cell Function and Interaction (7 papers) and Immunotherapy and Immune Responses (5 papers). Jiri Keirsse collaborates with scholars based in Belgium, Russia and United States. Jiri Keirsse's co-authors include Jo A. Van Ginderachter, Damya Laoui, Eva Van Overmeire, Qods Lahmar, Yvon Elkrim, Patrick De Baetselier, Yannick Morias, Kiavash Movahedi, Massimiliano Mazzone and Adélaïda Sarukhan and has published in prestigious journals such as Nature Communications, Genes & Development and Nature Reviews Drug Discovery.

In The Last Decade

Jiri Keirsse

19 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiri Keirsse Belgium 12 990 525 412 187 94 19 1.3k
Emilio Sanseviero United States 9 1.2k 1.2× 670 1.3× 411 1.0× 187 1.0× 114 1.2× 10 1.6k
Je-In Youn United States 8 1.3k 1.3× 622 1.2× 489 1.2× 309 1.7× 84 0.9× 9 1.7k
Elio Schouppe Belgium 10 764 0.8× 413 0.8× 274 0.7× 141 0.8× 85 0.9× 12 1.0k
Jens Serneels Belgium 10 807 0.8× 472 0.9× 559 1.4× 301 1.6× 91 1.0× 12 1.4k
Muhammad Baghdadi Japan 20 1.3k 1.3× 827 1.6× 422 1.0× 112 0.6× 57 0.6× 32 1.7k
Viktor Fleming Germany 9 1.3k 1.3× 938 1.8× 459 1.1× 179 1.0× 152 1.6× 10 1.8k
Serena Zilio Italy 13 1.2k 1.3× 674 1.3× 294 0.7× 87 0.5× 94 1.0× 16 1.5k
Joel Crespo United States 7 863 0.9× 674 1.3× 396 1.0× 183 1.0× 99 1.1× 8 1.4k
Michelle Collazo United States 5 1.9k 1.9× 807 1.5× 398 1.0× 97 0.5× 59 0.6× 6 2.1k
Evgenii N. Tcyganov United States 6 1.5k 1.5× 947 1.8× 509 1.2× 239 1.3× 158 1.7× 7 2.0k

Countries citing papers authored by Jiri Keirsse

Since Specialization
Citations

This map shows the geographic impact of Jiri Keirsse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiri Keirsse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiri Keirsse more than expected).

Fields of papers citing papers by Jiri Keirsse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiri Keirsse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiri Keirsse. The network helps show where Jiri Keirsse may publish in the future.

Co-authorship network of co-authors of Jiri Keirsse

This figure shows the co-authorship network connecting the top 25 collaborators of Jiri Keirsse. A scholar is included among the top collaborators of Jiri Keirsse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiri Keirsse. Jiri Keirsse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Tipanee, Jaitip, Mario Di Matteo, Warut Tulalamba, et al.. (2020). Validation of miR-20a as a Tumor Suppressor Gene in Liver Carcinoma Using Hepatocyte-Specific Hyperactive piggyBac Transposons. Molecular Therapy — Nucleic Acids. 19. 1309–1329. 10 indexed citations
2.
Keirsse, Jiri, Sandrine Delbauve, Yvon Elkrim, et al.. (2020). Myeloid tumor necrosis factor and heme oxygenase‐1 regulate the progression of colorectal liver metastases during hepatic ischemia‐reperfusion. International Journal of Cancer. 148(5). 1276–1288. 10 indexed citations
3.
Keirsse, Jiri, et al.. (2020). Developing blockbuster drugs: both nature and nurture. Nature Reviews Drug Discovery. 20(6). 421–422. 5 indexed citations
4.
Keirsse, Jiri, Helena Van Damme, Xenia Geeraerts, et al.. (2018). The role of hepatic macrophages in liver metastasis. Cellular Immunology. 330. 202–215. 48 indexed citations
5.
Keirsse, Jiri, Helena Van Damme, Jo A. Van Ginderachter, & Damya Laoui. (2017). Exploiting tumor-associated dendritic cell heterogeneity for novel cancer therapies. Journal of Leukocyte Biology. 102(2). 317–324. 24 indexed citations
6.
Geeraerts, Xenia, Evangelia Bolli, Jiri Keirsse, et al.. (2017). Beyond the M‐CSF receptor – novel therapeutic targets in tumor‐associated macrophages. FEBS Journal. 285(4). 777–787. 25 indexed citations
7.
Filtjens, Jessica, Jiri Keirsse, Sylvie Taveirne, et al.. (2016). Expression of the inhibitory Ly49E receptor is not critically involved in the immune response against cutaneous, pulmonary or liver tumours. Scientific Reports. 6(1). 30564–30564. 6 indexed citations
8.
Laoui, Damya, Jiri Keirsse, Yannick Morias, et al.. (2016). The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity. Nature Communications. 7(1). 13720–13720. 215 indexed citations
9.
Trez, Carl De, T. Baltz, Jiri Keirsse, et al.. (2016). Maintenance of B cells during chronic murine Trypanosoma brucei gambiense infection. Parasite Immunology. 38(10). 642–647. 7 indexed citations
10.
Overmeire, Eva Van, Benoı̂t Stijlemans, Felix Heymann, et al.. (2015). M-CSF and GM-CSF Receptor Signaling Differentially Regulate Monocyte Maturation and Macrophage Polarization in the Tumor Microenvironment. Cancer Research. 76(1). 35–42. 191 indexed citations
11.
Stijlemans, Benoı̂t, Jiri Keirsse, Lea Brys, et al.. (2015). Murine Liver Myeloid Cell Isolation Protocol. BIO-PROTOCOL. 5(10). 10 indexed citations
12.
Lahmar, Qods, Jiri Keirsse, Damya Laoui, et al.. (2015). Tissue-resident versus monocyte-derived macrophages in the tumor microenvironment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1865(1). 23–34. 123 indexed citations
13.
Overmeire, Eva Van, et al.. (2014). STAT of the union: Dynamics of distinct tumor‐associated macrophage subsets governed by STAT1. European Journal of Immunology. 44(8). 2238–2242. 12 indexed citations
14.
Laoui, Damya, Eva Van Overmeire, Jiri Keirsse, Kiavash Movahedi, & Jo A. Van Ginderachter. (2014). Purification of Tumor-Associated Macrophages (TAM) and Tumor-Associated Dendritic Cells (TADC). BIO-PROTOCOL. 4(22). 3 indexed citations
15.
Overmeire, Eva Van, Damya Laoui, Jiri Keirsse, & Jo A. Van Ginderachter. (2014). Hypoxia and tumor-associated macrophages. OncoImmunology. 3(2). e27561–e27561. 29 indexed citations
16.
Overmeire, Eva Van, Damya Laoui, Jiri Keirsse, Jo A. Van Ginderachter, & Adélaïda Sarukhan. (2014). Mechanisms Driving Macrophage Diversity and Specialization in Distinct Tumor Microenvironments and Parallelisms with Other Tissues. Frontiers in Immunology. 5. 127–127. 147 indexed citations
17.
Dániel, Bence, Gergely Nagy, Nasun Hah, et al.. (2014). The active enhancer network operated by liganded RXR supports angiogenic activity in macrophages. Genes & Development. 28(14). 1562–1577. 78 indexed citations
18.
Laoui, Damya, Eva Van Overmeire, Giusy Di Conza, et al.. (2013). Tumor Hypoxia Does Not Drive Differentiation of Tumor-Associated Macrophages but Rather Fine-Tunes the M2-like Macrophage Population. Cancer Research. 74(1). 24–30. 338 indexed citations
19.
Schouppe, Elio, Eva Van Overmeire, Damya Laoui, Jiri Keirsse, & Jo A. Van Ginderachter. (2013). Modulation of CD8+ T-cell activation events by monocytic and granulocytic myeloid-derived suppressor cells. Immunobiology. 218(11). 1385–1391. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emilio Sanseviero Breakdown of academic impact, for papers by Je-In Youn Breakdown of academic impact, for papers by Elio Schouppe Breakdown of academic impact, for papers by Jens Serneels Breakdown of academic impact, for papers by Muhammad Baghdadi Breakdown of academic impact, for papers by Viktor Fleming Breakdown of academic impact, for papers by Serena Zilio Breakdown of academic impact, for papers by Joel Crespo Breakdown of academic impact, for papers by Michelle Collazo Breakdown of academic impact, for papers by Evgenii N. Tcyganov
Rankless by CCL
2026